HBV Capsid inhibitor 3711
CAS No. 2041072-40-4
HBV Capsid inhibitor 3711 ( Compound 3711 )
Catalog No. M13173 CAS No. 2041072-40-4
HBV Capsid inhibitor 3711 (Compound 3711) is a nonnucleosidic HBV inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHBV Capsid inhibitor 3711
-
NoteResearch use only, not for human use.
-
Brief DescriptionHBV Capsid inhibitor 3711 (Compound 3711) is a nonnucleosidic HBV inhibitor.
-
DescriptionHBV Capsid inhibitor 3711 (Compound 3711) is a nonnucleosidic HBV inhibitor, inhibits hepatitis B virus replication by inducing genome-free capsid formation; decreases extracellular HBV DNA levels and intracellular DNA levels with EC50 of 1.5 and 1.9 uM in a cell model system; shows sensitivity against both the 3TC/ETV dually resistant L180M/M204I mutant and the adefovir (ADV)-resistant A181T/N236T mutant; decreases levels of HBV DNA contained in both secreted enveloped virion and naked virus particles in supernatant, interferes with capsid formation of the core protein (Cp) assembly domain.
-
SynonymsCompound 3711
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2041072-40-4
-
Formula Weight367.83
-
Molecular FormulaC20H18ClN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(4-(1-(4-chlorobenzyl)-5-methyl-6-oxo-1,6-dihydropyridazin-3-yl)phenyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Feng S, et al. ACS Infect Dis. 2018 Mar 9;4(3):257-277.
2. Wang YJ, et al. Antimicrob Agents Chemother. 2015 Nov;59(11):7061-72.
2. Wang YJ, et al. Antimicrob Agents Chemother. 2015 Nov;59(11):7061-72.
molnova catalog
related products
-
BCM-599
BCM-599 is an efficient HBV capsid assembly inhibitor with in vitro IC50 of 13 uM, shows synergistic inhibitory effects on decreasing viral concentration combined with lamivudine in vivo.
-
Inarigivir ammonium
Inarigivir ammonium is a dinucleotide antiviral compound that significantly reduces HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir is an agonist of retinoic acid-inducible gene-I (RIG-I) that activates intracellular innate immunity.
-
Bay 41-4109 racemate
The racemate form of Bay 41-4109, which is a potent, non-nucleosidic inhibitor of HBV nucleocapsid maturation with IC50 of 0.05 uM.